Generic Pharmaceutical Exhibitions and Conferences 05

Please email info@genericsweb.com to request a conference or exhibition be added to this list.

- Click here to view '06 records -

05:
December | November | October | September | August | July | June | May | April | March | February | January  

Chemical World 2005
15-19 December, Ahmedabad: Exhibition on Chemicals, Chemical Plant & Equipment, Pharmaceutical and Process Industry.

Regulatory Challenges in the CEE Pharmaceutical Market
5-8 December, Warsaw: Seminar titles include; Assess the Impact of Parallel Trade on your Business, and Build a Robust Pricing Strategy & Tackle The Reimbursement Crisis.

Interchimie Maroc 2005
7-10 December, Casablanca: Mediterranean Exhibition for Chemical, Pharmaceutical & Cosmetical Technologies.

Generics IP
8-9 December, Berlin: Getting the most out of data exclusivity.

EURO Plx 26 Porto
30 November  - 1 December, Lisbon: Proposed orientation of EuroPLX 26 is towards collaborative agreements in dossiers, custom synthesis, contract manufacture, R&D services, and supply of APIs.

11th Annual EGA Conference
21-22 November, Berlin: 'Ensuring a Competitive Environment for Generic Medicines in Europe', this two-day conference of the European Generic Medicines Association (EGA) will focus on measures to ensure a positive competitive environment for the sustainable delivery of cost-effective generic medicines. Topics include pricing and reimbursement, regulatory and IP issues, and current German healthcare reforms. The conference will end with a panel discussion with leading CEOs from the European generic medicines industry.

5th Annual Forum on Generic Drugs
17-18 November, Washington: Topics include 30 month stays and 180 day exclusivities, forfeiture events, medicare reforms, authorized generics, market excusivity, generic biologics, and the Indan generics market.

CPhI / ICSE / P-Mec
1-3 November, Madrid: International Exhibition on Pharmaceutical Ingredients and Intermediates / Contract Services / Pharmaceutical Manufacturing. Look for GenericsWeb at Stand H41, Hall 5.

China-Pharm 05
25-28 October, Shanghai: The 10th China International Pharmaceutical Industry Exhibition Participation of the Federal Ministry of Economics and Labour

EuroPLX 25
8-9 October, Zurich: Proposed orientation of EuroPLX 25 is towards collaborative agreements in prescription drugs, patented or generic, as well as drug delivery technology.

Pharma India
1-3 October, Delhi: International Exhibition & Conference for Pharmaceutical Industry, Raw Materials, Manufacturing and Packaging Industry.

IPC 2005
Symposiums September 26-27, one-on-one meetings 28,  Regulatory workshop 29-30, Shanghai: IPC 2005 will be focused on the business and market development in sourcing and outsourcing partnership of pharmaceutical ingredients and finished products for generics. There will be four symposiums at IPC 2005: (1) Sourcing Partnership for APIs and Intermediates, (2) From APIs Sourcing to Generics Outsourcing, (3) Intellectual Properties of APIs and Generics, and (4) Outsourcing Partnership for APIs and Intermediates. Workshop; Regulatory and Technical Requirements of European Marketing Authorization of APIs.

Expopharm
22-25 September, Cologne:  International Pharmaceuticals Fair. 

Licensing In The Generics Industry
15-16 September, Berlin: Beating the Competition through In- and Out- Licensing. Topics inlcude: Generics Trends on the Market, Getting the most out of European Licenses, Beating off the Competition, and Patent issues- Safeguarding your Market Share.

API's Europe
14-16 September, Lake Como, Italy : The best of the European API industry join together to  show its latest development to a selected number of invited international end users; an international Conference with a Gala Dinner.

Indonesia International Pharma Expo
7-10 September, Jakarta: International Exhibition on Pharmaceutical, Raw materials, Active Ingredients, Processing Machinery, Packaging Machinery & Equipments.

EuroPLX 24
29-30 June, Amsterdam: Global bio/pharma industry partnering event.  Proposed orientation of EuroPLX 24 is towards collaborative agreements in clinical and approved, patented drugs.